VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
No Rocuronium
Preclinical
Small molecule
F
Federico Longhini
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Thyroid Surgery
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Thyroid Surgery
Preclinical
Completed
Clinical
Trials by Indication
[1]
Thyroid Surgery
1 trial
Anaesthesia With or Without Rocuronium in Intubation and Intraoperative Nerve-monitoring During Thyroid Surgery.
Completed
·
F
Federico Longhini
·
N/A
·
NCT03910504
·
100 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for No Rocuronium. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
No Rocuronium compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for No Rocuronium. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Federico Longhini company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
F
Federico Longhini
Related News